Abstract
Jejunoileal bypasses were performed in rats to determine the effect of improved absorption on the development of liver dysfunction occurring after this procedure. Several parameters of liver function were measured in rats 7 weeks after both the standard 85% small-bowel, bypass and an 80% bypass in which an extra 5 cm of intact bowel was retained. Animals having undergone 80% bypass had a lesser degree of lowering of serum protein and triglyceride levels, hepatic cytochrome P-450 content, and hepatic glucose-6-phosphatase activity than did the animals undergoing 85% bypass. Abnormalities found in 85% bypassed animals were only partially reproduced by reducing food intake in another group of 80% bypassed animals. These findings emphasize the importance of, nutritional factors in the etiology of bypass-induced liver disease and militate against toxin production in the defunctionalized bowel as the sole cause of liver dysfunction following bypass.
Similar content being viewed by others
References
Payne JH, DeWind LT, Commons RR: Metabolic observation in patients with jejunoileal shunts. Am J Surg 106:273–298, 1963
Payne JH, DeWind LT: Surgical treatment for obesity. Am J Surg 118:141–147, 1969
Scott HW Jr, Sanstead HH, Brill AB, Burko H, Younger RK: Experience with a new technique of intestinal bypass in the treatment of morbid obesity. Ann Surg 174:560–572, 1971
Dublin LT, Marks HH: Mortality among insured overweight in recent years.In Transactions of the Association of Life Insurance Medical Directors of America. Sixtieth Annual Meeting. 35:235, 1951
National Center for Health Statistics. Weight and height and age of adults. United States 1960–1962. Vital and Health Statistics. Public Health Service Publication No. 1000 Series 11, No. 14, Washington, DC, US Government Printing Office, May 1966
De Wind LT, Payne JH: Intestinal bypass surgery for morbid obesity—long term results. J Am Med Assoc 236:2298–2301, 1976
Benfield JR, Greenway FL, Bray GA, Barry RE, Lechago J, Mena I, Schedwie H: Experience with jejunoileal bypass for obesity. Surg Gynecol Obstet 143:401–410, 1976
Hollenbeck JI, Oleary JP, Maher JW, Woodward ER: An etiological basis fatty liver after jejunoileal bypass. J Surg Res 18:83, 1975
Hyland G, Stein T, Wise L: Abnormalities of liver function following extensive jejunoileal bypass and resection in rats. Surgery 81:570–582, 1977
Fogel MR, Ravitch MM, Adibi SA: Absorption and d gestive function of the jejunum after jejunoileal bypass for treatment of human obesity. Gastroenterology 71:729–733, 1976
Heimburger SL, Steinger E, LoGerfo P, Biehl AG, Williams MJ: Reversal of severe fatty infiltration after intestinal bypass for morbid obesity by calorie free amino acid infusion. Am J Surg 129:229–235, 1975
Lockwood DH, Amatruda JM, Moxley RT, Pozefsky T, Boitnott JK: Effect of oral amino acid supplementation on liver disease after jejunoileal bypass for morbid obesity. Am J Clin Nutr 30:58–63, 1977
Burney DP, Burnham SJ, Hough AJ, Scott HW: Experimental short gut: Hepatic alterations after jejunoileal resection, bypass and vibramycin therapy. Am Surg 43:779–786, 1977
Folch J, Lees M, Sloan-Stanley GH: A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem 226:497–509, 1957
Soloni FG: Simplified manual micromethod for determination of serum triglycerides. Clin Chem 17:529–532, 1971
Lowry OH, Rosenbrough NJ, Farr AL, Randall RJ: Protein measurement with the Folin phenol reagent. J Biol Chem 193:265–275, 1951
Greim H: Synthesesteigerung und abbanhemmung bei der vermehrung der mikrosomalen cytochrome P-450 und b-5 durch phenobarbital. Naunyn-Schmiedebergs Arch Pharmakol 226:271–275, 1970
Joly J-G, Doyon C, Peasant Y: Cytochrome P-450 measurement in rat liver homogenate and microsomes. Drug Metab Dispos 3:577–586, 1975
Harper AE: Glucose-6 phosphatase.In Methods of Enzymatic Analysis, HU Bergmeyer (ed.) New York, Academic Press, 1963, pp. 788–792
Vanderhoof JA, Tuma DJ, Sorrell MF: Role of the defunctionalized bowel in jejunoileal bypass-induced liver disease in rats. Dig Dis Sci 24:916–920, 1979
Tuma DJ, Vanderhoof JA, Sorrell MF: Impaired hepatic drug metabolism after jejunoileal bypass in rats. J Pharmacol Exp Ther 206:167–171, 1978
Grosfeld JL, Harris RA, Csicsko JF, Cooney DR, Madura JA. Adverse effects of jejunoileal bypass on growth and development. Surgery 80:201–207, 1976
Grosfeld JL, Harris RA, Csicsko JF, Cooney DR, Madura JA: Increased hepatic synthesis of cholesterol following jejunoileal bypass. Surgery 81:701–707, 1977
Sclafani A, Koopmans HS, Vasselli JR, Reichman M: Effects of intestinal bypass surgery on appetite, food intake, and body weight in obese and lean rats. Am J Physiol 234:E389, 1978
Viddal KO, Nygaard K: Intestinal bypass, a comparison between two different bypass operations and resection of the small intestine in rats. Scand J Gastroenterol 12:465–472, 1977
McClelland RN, DeShazo CV, Heimbach DM, Eigenbrodt EH, Dowdy ABC: Prevention of hepatic injury after jejunoileal bypass by supplemental jejunostomy feedings. Surg For 21:368–370, 1970
Author information
Authors and Affiliations
Additional information
This work was supported in part by the Swanson Center for Nutrition, Inc., and the Veterans Administration Medical Center, Research Service, Omaha, Nebraska.
Rights and permissions
About this article
Cite this article
Vanderhoof, J.A., Metz, M.J., Tuma, D.J. et al. Effect of improved absorption on development of jejunoileal bypass-induced liver dysfunction in rats. Digest Dis Sci 25, 581–586 (1980). https://doi.org/10.1007/BF01318870
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01318870